Mexico HLA Typing Market (2025-2030)
The Mexico HLA Typing Market was valued at $26.8 Million in 2025 and projected to reach to $30.6 Million by 2030, representing a compound annual growth rate of 2.7%. Mexico's HLA typing market is positioned for steady growth as the country strengthens its healthcare infrastructure and expands access to advanced diagnostic services.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Mexico HLA Typing Market Trends and Insights
- This moderate growth trajectory reflects Mexico's developing healthcare infrastructure and increasing adoption of immunogenetic testing for organ transplantation and disease diagnosis.
- Mexico's market expansion is driven by rising transplant volumes, improved laboratory capabilities, and growing awareness of HLA testing's clinical significance in patient outcomes. The HLA typing market in Mexico remains relatively nascent compared to developed nations, with significant growth potential as healthcare investment increases across the country.
- Mexico's forecast period (2025–2030) will likely see enhanced diagnostic capacity and greater integration of HLA testing into routine clinical practice.
- Key drivers include Mexico's aging population, increased prevalence of chronic diseases requiring transplantation, and strengthening regulatory frameworks that mandate HLA compatibility testing for organ allocation..
Key Market Statistics
- CAGR (2025-2030) 2.7% CAGR
- Market Size, 2025 ~USD 26.8 Million
- Forecast, 2030 ~USD 30.6 Million
- Country Mexico
Mexico HLA Typing Market Overview
Market Valuation :
Mexico's HLA typing market is valued at $26.8 million in 2025, with projected growth to $30.6 million by 2030, representing a steady expansion in immunogenetic testing adoption.
Growth Rate :
The Mexican market is expanding at a CAGR of 2.7%, reflecting moderate but consistent growth driven by healthcare infrastructure improvements and increased transplantation procedures.
Key Driver: Transplantation :
Rising organ transplantation demand in Mexico is a primary catalyst for HLA typing adoption, as immunogenetic testing is essential for matching donor-recipient compatibility and improving transplant outcomes.
Healthcare Infrastructure Development :
Mexico's developing healthcare system is increasingly investing in diagnostic capabilities, creating opportunities for HLA typing services in both public and private medical institutions.
Mexico HLA Typing Market Dynamics
- The market benefits from rising organ transplantation rates and growing awareness of immunogenetic testing applications in disease diagnosis and treatment planning.
- Healthcare modernization initiatives and increased investment in laboratory capabilities are expected to support market expansion through 2030. The Mexican market's moderate 2.7% CAGR reflects the gradual adoption pace typical of developing healthcare systems, yet presents significant opportunities for market entrants.
- Partnerships with local hospitals, transplant centers, and diagnostic laboratories will be crucial for capturing market share.
- As Mexico continues to enhance its medical infrastructure and regulatory frameworks, HLA typing services are anticipated to become more accessible, particularly in major metropolitan areas and specialized medical centers..
Related Ecosystem
Key Takeaways
- Mexico's HLA typing market is valued at $26.8 million in 2025 with a projected value of $30.6 million by 2030.
- Mexico experiences a 2.7% CAGR, reflecting steady but moderate growth in immunogenetic testing adoption.
- Mexico's market growth is driven by increased transplant demand, improved laboratory infrastructure, and regulatory compliance requirements.
- Mexico's HLA typing market remains underpenetrated relative to developed markets, presenting significant expansion opportunities through 2030.
HLA Typing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | COMMERCIAL SERVICE PROVIDERS (End User) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6% from 2025 to 2030 |
| Largest Segment | DIAGNOSTIC APPLICATIONS (Application) |
| Market Size Base Year (Billions) | ~USD 1.72 (2025) |
| Revenue Forecast (Billions) | ~USD 2.3 (2030) |
| Segments Covered | Product & Service, Technology, Type, Application, End User, Diagnostic Application |
Mexico HLA Typing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents & Consumables
- Software & Services
By Technology
- Molecular Assay Technologies
- Non-Molecular Assay Technologies
By Type
- Cancer Diagnosis & Prevention
- Donor-Recipient Cross-Matching
- Infectious Disease Testing
- Next-Generation Sequencing
- Other Diagnostic Applications
- Other Pcr-Based Molecular Assays
- Other Sequencing-Based Molecular Assays
- Pcr-Based Molecular Assays
- Real-Time Pcr
- Sanger Sequencing
- Sequence-Specific Oligonucleotide-Pcr
- Sequence-Specific Primar-Pcr
- Sequence-Specific Primer-Pcr
- Sequencing-Based Molecular Assays
- Transfusion Therapy
By Application
- Diagnostic Applications
- Research Applications
By End User
- Commercial Service Providers
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
By Diagnostic Application
- Cancer Diagnosis & Prevention
- Donor-Recipient Cross-Matching
- Infectious Disease Testing
- Other Diagnostic Applications
- Transfusion Therapy
Target Audience
- Diagnostic Laboratory Operators : Mexican and international laboratory operators need market data to assess expansion opportunities, understand local demand for HLA typing services, and plan capital investments in testing infrastructure.
- Medical Device & IVD Manufacturers : Companies developing HLA typing reagents and equipment require Mexico-specific market intelligence to evaluate distribution strategies, identify key hospital and transplant center customers, and forecast sales potential.
- Healthcare System Administrators : Hospital networks and healthcare institutions in Mexico need market insights to justify investments in immunogenetic testing capabilities, understand competitive offerings, and plan service expansion.
- Investment & Consulting Firms : Private equity, venture capital, and management consultants require detailed Mexico market data to evaluate acquisition targets, assess growth potential, and develop market entry strategies for healthcare clients.
- Transplant Program Directors : Organ transplant centers and procurement organizations in Mexico need market information to benchmark HLA typing service quality, understand technology trends, and optimize donor-recipient matching protocols.
Key Companies in the Mexico HLA Typing Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BGI GENOMICS | China | Public Company | Sequencing-based HLA services (NGS, immune repertoire, WES/WGS-derived typing),Reagents & consumables for HLA workflows,Instruments (sequencers and related hardware used for HLA), |
| BECTON DICKINSON AND CO | United States | Public Company | Instruments,Reagents,Software, |
| BD | United States | Public Company | Instruments,Reagents,Software, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Sequencing-based HLA (NGS, Sanger),PCR-based HLA (SSO, SSP, Real-time),Software and Informatics, |
| ILLUMINA, INC. | United States | Public Company | Sequencing Instruments (NGS platforms used for HLA typing),Sequencing Reagents, Flow Cells, and Library Prep for HLA,Software and DRAGEN-based Secondary Analysis for HLA, |
| QIAGEN | Netherlands | Public Company | Reagents & Consumables (PCR, NGS, sample technologies for HLA workflows),Instruments (PCR, NGS-related, automation, QC),Software & Bioinformatics (HLA analysis, SaaS, interpretation), |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Reagents & Consumables (PCR and sequencing HLA kits),Instruments (PCR, sequencing-adjacent, and automation),Software & Informatics (HLA analysis, LIS connectivity), |
| F. HOFFMANN-LA ROCHE LTD | United States | ||
| CAREDX, INC. | United States | Public Company | HLA Typing Reagents & Assays (PCR SSO/SSP, Real-time, NGS, Sanger),Instruments & NGS Workflow Components,Software (Ottr, HLA Data Systems, XynQAPI, MedActionPlan, others), |
| DIASORIN S.P.A. | Italy | Public Company | Instruments,Reagents,Software, |
| EUROBIO SCIENTIFIC | France | Public Company | Reagents (PCR and NGS HLA typing),Software (HLA typing analysis and reporting),Instruments (sequencers, ancillary lab systems), |
BGI GENOMICS
BGI Genomics is a Chinese public company founded in 1999 that employs 3,580 people. The company operates in the genomics and genetic sequencing sector.
BECTON DICKINSON AND CO
Becton Dickinson and Co is a United States-based public company founded in 1897 with 72,000 employees. The company operates in the medical devices and diagnostics sector.
BD
BD is a United States-based public company founded in 1897 with 72,000 employees. The company operates in the medical devices and diagnostics sector.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company operates in the life sciences and diagnostics industry.
ILLUMINA, INC.
Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. The company specializes in DNA sequencing and genetic analysis technologies.
QIAGEN
QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees. The company operates in the molecular diagnostics and life sciences sector.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.
F. HOFFMANN-LA ROCHE LTD
Insufficient data available to provide a business description for this company.
CAREDX, INC.
CareDx, Inc. is a United States-based public company founded in 1998 with 763 employees. The company operates in the molecular diagnostics and transplant monitoring sector.
DIASORIN S.P.A.
DiaSorin S.p.A. is an Italy-based public company founded in 1968 with 3,242 employees. The company specializes in diagnostic solutions and immunoassay products.
EUROBIO SCIENTIFIC
Eurobio Scientific is a France-based public company founded in 1997 with 343 employees. The company operates in the life sciences and diagnostics industry.
Reasons to Buy this Report
- Market-Specific Sizing Data : Access precise valuation figures for Mexico's HLA typing market ($26.8M in 2025) with detailed forecasts through 2030, enabling accurate budget allocation and revenue projections for market entry strategies.
- Growth Opportunity Assessment : Understand Mexico's 2.7% CAGR trajectory compared to global 6% growth, identifying specific market dynamics and localized factors driving slower adoption to optimize competitive positioning.
- Transplantation Market Insights : Gain intelligence on Mexico's organ transplantation sector as the primary HLA typing demand driver, including procedure volumes, hospital capabilities, and regional distribution of transplant centers.
- Healthcare Infrastructure Analysis : Evaluate Mexico's developing diagnostic infrastructure, regulatory environment, and investment trends to identify partnership opportunities and market entry barriers in public and private healthcare segments.
- Competitive Landscape Intelligence : Benchmark against regional competitors and understand market consolidation patterns specific to Mexico, enabling strategic positioning and differentiation in this emerging immunogenetic testing market.
Frequently asked questions
What is the current size of Mexico's HLA typing market?
Mexico's HLA typing market is valued at $26.8 million in 2025 and is expected to reach $30.6 million by 2030.
What is the growth rate of Mexico's HLA typing market?
Mexico's HLA typing market is growing at a compound annual growth rate (CAGR) of 2.7% from 2025 to 2030.
What factors are driving growth in Mexico's HLA typing market?
Mexico's HLA typing market growth is driven by rising organ transplant volumes, enhanced laboratory capabilities, regulatory mandates for HLA testing, and increased clinical awareness of immunogenetic testing benefits.
How does Mexico's HLA typing market compare to global trends?
Mexico's 2.7% CAGR is lower than the global 6% CAGR, reflecting Mexico's developing healthcare infrastructure and lower market penetration relative to mature markets.
What is the forecast for Mexico's HLA typing market by 2030?
Mexico's HLA typing market is forecast to reach $30.6 million by 2030, representing a $3.8 million increase from the 2025 baseline of $26.8 million.
RESEARCH METHODOLOGY
This research study extensively utilized secondary sources, directories, and databases to identify and gather valuable information for analyzing the global HLA typing market. Additionally, in-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives from leading market players, and industry consultants. These interviews helped obtain and validate critical qualitative and quantitative data while assessing the growth prospects. The global market size, initially estimated through secondary research, was then refined and finalized through triangulation with insights from primary research.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the HLA typing market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various companies and organizations in the HLA typing market. The primary sources from the demand side include OEMs, private and contract testing organizations, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The bottom-up approach was used to estimate and validate the total size of the HLA typing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- A list of the major global players operating in the HLA typing market was generated.
- Mapping annual revenues generated by major global players from the HLA typing segment (or nearest reported business unit/service category)
- Revenue mapping of key players to cover a major share of the global market as of 2024
- Extrapolating the global value of the HLA Typing industry
Global HLA Typing Market Size: Bottom-up Approach and Top-down Approach
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
HLA typing is a genetic procedure to determine donor-recipient compatibility, cancer & autoimmune disorder diagnosis, pathogen testing, and transfusion therapy. Additionally, it is used in drug testing, disputed paternity, and anthropological studies. Advanced genomic techniques, such as PCR and NGS, are increasingly being used in HLA typing, apart from serological and other conventional techniques for immuno-compatibility testing.
Stakeholders
- HLA Typing Product Manufacturers
- Healthcare Service Providers (Hospitals, Transplant Centers, and Blood Transfusion Centers)
- Blood, Tissue, and Stem Cell Banks
- Government Organizations
- Independent Associations and Regulatory Authorities
- R&D Companies
- Independent Reference Laboratories
- Diagnostic Laboratories
- Clinical Research Organizations
- Research Laboratories and Academic Institutes
Report Objectives
- To define, describe, and forecast the HLA typing market based on technology, product & service, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global HLA typing market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global HLA typing market
- To analyze key growth opportunities in the global HLA typing market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa (GCC Countries and Rest of Middle East & Africa)
- To profile the key players in the HLA typing market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global HLA typing market, such as agreements, expansions, and acquisitions
Get the Full HLA Typing Market Report
Full forecast, segment splits, and company analysis for all HLA Typing Market.
- Canada HLA Typing Market
- US HLA Typing Market
- Germany HLA Typing Market
- UK HLA Typing Market
- France HLA Typing Market
- Spain HLA Typing Market
- Italy HLA Typing Market
- China HLA Typing Market
- Japan HLA Typing Market
- India HLA Typing Market
- South Korea HLA Typing Market
- Australia HLA Typing Market
- Brazil HLA Typing Market
- Rest Of Europe HLA Typing Market
- Rest Of Asia HLA Typing Market
- Rest Of Latin America HLA Typing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
